What we're reading, June 15, 2016: opioids also linked to heart-related deaths and fatalities other than overdoses; judge overrules Federal Trade Commission's efforts to block merger of Advocate Health Care and NorthShore University HealthSystem in Illinois; and using social media to monitor patients outside of the healthcare setting.
Opioids may also be linked to heart-related deaths and other fatalities in addition to overdose deaths. According to the AP, a study found that while 64% of patients taking opioids had a higher risk of dying within 6 months of starting their medication, only 18% of deaths were due to unintentional overdoses. The prescription painkillers are responsible for slowing breathing or worsening the type of disrupted breathing that occurs with sleep apnea, ultimately resulting in heart attacks or death.
In Illinois, a federal judge has overruled efforts by the Federal Trade Commission (FTC) to block a merger of 2 hospital systems. The FTC was interested in preventing the deal because it felt the system emerging as a result of the merger of Advocate Health Care and NorthShore University HealthSystem would dominate the North Shore area of Chicago, reported The New York Times. The judge’s reasoning has not been explained yet, but his decision will be released after the hospital systems can redact sensitive competitive information.
Doctors could start using social media to follow patients’ health issues. FastCompany reported that people are using social media to discuss health issues they normally don’t tell their doctors, which providers can use to monitor patients outside of a healthcare setting. However, few health systems are currently equipped to eal with remote patient monitoring.
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Technology Takes Center Stage at the 2025 AAD Annual Meeting
March 14th 2025The role of artificial intelligence, DataDerm, and telehealth in advancing dermatology care was discussed throughout the meeting, with experts highlighting their potential regarding patient access and health equity.
Read More